Balmadres, Kizeah R.

HRN: 23-45-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/21/2026
CEFUROXIME 750MG (VIAL)
02/21/2026
02/28/2026
IV
350mg
Q8
AGE
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: